Research Innovation (Branded) or Generics – Which is the Better Bet?

-

Proportion of branded versus generic prescription drug revenues in the United States from 2005 to 2016

2

Pricing of Drugs:

The Various Factors that may be considered by a Pharma Company for setting the Price of a drug.

  1. Patent Status: If the drug is patented it is usually priced high because for that time no other company can manufacture it.
  2. Uniqueness: The uniqueness of the drug must be considered i.e., how many other drugs are already available to treat the same condition.
  3. Competition: Popularity and Success of the drug’s competition plays an important factor as the aggressiveness of competition may put pressure on the drug pricing.
  4. Added benefits over competing drugs – Added benefits usually lead to higher prices.
  5. Potential to change the current practice of medicine like dosage route & schedule, can be taken without food etc.
  6. Delay the progression of disease or avoid surgical treatment: As delay in surgery or progression of disease can save a lot of cost for the patient, it can help in pricing the drug on higher side.
  7. Health Economics – Number of working days gained by this modality of treatment.
  8. Life Saving Drug
  9. Health Insurance payment Policies- coverage of drug in insurance policies.
  10. Institutional business Pricing for Bulk selling.
  11. R & D expenditure that has been already done need to be recovered too.

If we look at the above mentioned factors of pricing, it clearly gives a hint that a new branded drug usually ticks most of the factors & that too on a positive note. Due to this the pricing of Branded drugs is on a higher side. As the price is high & patent of drug is active, the low volume sales may bring cash fortunes for the company. If the company can market the drug in an aggressive mode & to the right target patients, then sky is the limit.

From the above discussion & the data from US drug market, it is quite evident that putting money in Research & Development for Drug Innovation is always beneficial in the long run. The US market shows a revenue share of more than 70% in the favor of branded drugs even if the volume proportion of Generics may be on higher side.

Indian Perspective & Make in India

Make in India lion111

In context of Make in India, Indian Pharma has to be considered within top 5 Industries.  Indian Pharma Industry is in top five among industries pertaining to exports figures. Indian Pharma is at top spot in relation to Generics manufacture & export but there is a felt need of shifting focus on Research-Innovations to produce branded drugs of high repute. It is high time to create a sustainable research & innovation based model which can make Indian Pharma Sector Numero-Uno .

Reference

https://www.statista.com/statistics/205036/proportion-of-brand-to-generic-prescription-sales/

For any Feedback or suggestion mail at: info@pharmastate.com

Weblink – https://pharmastate.com/

Applink- https://goo.gl/mS8Lr7

 

 

 

PharmaState Blog
This is a platform for people working in the pharmaceuticals industry for Discussions, Jobs, News updates, Professional Profile display space and company business pages. PharmaState DNA is having four pillars: Quality, Transparency, Innovation & Benchmarks.

Share this article

Recent posts

Popular categories

Leave a Reply

Recent comments

Business Alnavedic on History of Indian Pharma Industry
Ahmed Mohamed Elkhodragy on MACO Calculation
Jennifer Osunde on DEFECTS IN UNCOATED TABLETS
Vinod on DEVIATION
Rajib ghose on TOOLING FOR TABLETING
K. SRinivasula Reddy on Quality Agreements – PART 2
Sunil Kumar M on SITE ACCEPTANCE TEST (SAT)
Khalid on IQ Protocol
Khalid on IQ Protocol
Nagabooshanam on Calibration of Reactor
PharmaState Blog on SOP for Sampling
Swapnil Khodake on TOOLING FOR TABLETING
%d bloggers like this: